(2026) -
Chronological (1733 items)
(All links open in new tab)
| Oct 20, 2026 |
Recent Studies Debunk Anti-Cannabis Industry Talking Points
A trio of recent studies provides evidence that directly contradicts major talking points that are often used by special interests opposed to the legal cannabis industry. The first pertains to crime, the second to youth cannabis consumption, and the third to motor vehicle safety. Cannabis industry opponents frequently make the claim that if legal cannabis sales are permitted, a spike in crime will occur in the area surrounding where legal sales are allowed. A researcher at Brock University examined crime data in Toronto and Ottawa, where adult-use cannabis sales are legal. His findings were published in The International Journal of Drug Policy. |
|---|---|
| Oct 20, 2026 |
Trump losing ground with cannabis consumers ahead of midterms
Cannabis consumers are increasingly dissatisfied with the Trump administration’s handling of marijuana policy. A recent poll shows major declines among the demographic, as advocates continue to wait for broader reform and a hemp ban looms. The survey from NuggMD and Marijuana Moment revealed that 29 percent of cannabis consumers either approve or strongly approve of the administration’s actions on the plant. That’s a major drop from the July quarterly poll, when support was 48 percent. |
| Oct 20, 2026 |
Opening Legal Marijuana Dispensaries Provides An Economic Boost For Nearby Businesses, Study Shows
The opening of recreational marijuana dispensaries can help boost nearby businesses by increasing foot traffic, purchases and revenue, according to a new study. Researchers from the City University of New York, Northern Illinois University and University of Miami examined cannabis market growth, credit and debit card purchases and socioeconomic and demographic data in Illinois from 2021 through 2024, finding that “recreational dispensary openings increase the number of customers at nearby establishments by approximately 6.82%, transactions by 8.01%, and revenue by 7.47%.” |
| Oct 19, 2026 |
Study Finds THC-Rich Marijuana Extracts Trigger Leukemia Cell Death and Immune-Response Signals
THC-rich marijuana extracts triggered programmed cell death in leukemia cells while activating biological signals associated with immune recognition of cancer, according to new research accepted for publication in Frontiers in Immunology. The study, conducted by researchers affiliated with the Juan N. Corpas University Foundation in Bogotá, Colombia, examined how marijuana extracts with different THC and CBD concentrations affected two human leukemia cell lines and the activity of immune cells known as macrophages. |
| Oct 19, 2026 |
Legal Retailers Welcome Ontario’s Plan to Target Illegal Cannabis Shops
The Ontario government says it plans to strengthen enforcement against illegal cannabis sales in the province. The proposed changes will be part of an upcoming legislative package. They would give the Alcohol and Gaming Commission of Ontario (AGCO) new tools to address unauthorized cannabis storefronts and unlawful online retail operations, including the authority to conduct inspections, seize illegal cannabis products and equipment, and issue administrative monetary penalties. |
| Oct 19, 2026 |
NORML Files Amicus Brief in Case Over Enforceability of Cannabis-Related Contracts
Members of the NORML Legal Committee – led by attorney William Swor of Detroit, Michigan – have filed a friend-of-the-court (amicus) brief urging the US Court of Appeals for the Sixth Circuit to reconsider its decision that cannabis industry contracts are not enforceable as long as marijuana is federally prohibited. Specifically, the Appeals Court ruled in September that federal courts cannot award breach-of-contract damages in situations that enforce an agreement specific to conduct that is prohibited by the US Controlled Substances Act. |
| Oct 19, 2026 |
European Cannabis at the Crossroads: Regulation Across Borders
The 2026 report from the European Union Drugs Agency (EUDA) highlights that cannabis policies in Europe are evolving at varying rates and in different directions. Germany, Malta and Spain have established different frameworks for adult-use cannabis; Luxembourg and Czechia have introduced limited home cultivation, while the Netherlands is testing regulated cannabis supply. At the same time, other countries maintain much more restrictive approaches. |
| Oct 19, 2026 |
Here’s the Hands-Down Best Cannabis Stock for Dividend Investors
Many income investors wouldn't go near a pot stock with a 10-foot pole -- and for good reason. For one thing, most cannabis stocks don't pay dividends. The ones that do operate in a highly volatile industry. However, it's important to remember the adage "don't throw the baby out with the bath water." Sure, most cannabis stocks aren't good picks if you're seeking reliable income. There's one, though, that I think is hands-down the best cannabis stock for dividend investors. If you want cannabis exposure without cannabis-company risk, along with an exceptionally juicy yield, check out Innovative Industrial Properties 9.00% Series A Cumulative Redeemable Preferred Stock (NYSE: IIPR-PA). |
| Oct 19, 2026 |
Curaleaf Continues Fight After Raising Takeover Bid for Aurora Cannabis
Curaleaf today responded to Aurora Cannabis recommending that its shareholders reject Curaleaf's increased takeover proposal, extending the companies' public battle over a potential deal. "Aurora's Board has a fiduciary duty to shareholders, which requires it not to take illogical steps to keep the highest bidder out of the room. The board has locked out Curaleaf while granting diligence access to unnamed parties and cites selective sources to support its agenda. None of that reflects a board acting in the company's or shareholders' best interests. Shareholders deserve the facts, and the facts favor engagement, not obstruction," said Curaleaf CEO Boris Jordan in a statement. |
| Oct 19, 2026 |
Devils on the loose: The deadly cost of Kanehsatà:ke’s cannabis boom
The cannabis industry is booming here and it has transformed the community into a volatile battleground. What started with a single unlicensed shop in 2018 has exploded into roughly 30 dispensaries, including megastores and casinos lining the main thoroughfare. Some play loud music all day, light up the night sky with neon and attract massive crowds. Even rapper Snoop Dogg performed here two years ago. |
| Oct 19, 2026 |
Cannabis is getting stronger, but doubling THC dose doesn’t get you twice as ‘high’ – new study
Cannabis products are getting more potent and easier to buy around the world. Yet little is known about how bigger doses of tetrahydrocannabinol (THC), the main active ingredient in cannabis, change what people feel. Our new research found that larger doses generally make people feel more high, but not in a straight line. Doubling the dose does not double the feeling of intoxication. |
| Oct 19, 2026 |
Bolsonaro vs. Lula: Brazil’s Runoff Could Decide Who Profits From Cannabis in a Country of 200 Million
Flávio Bolsonaro, son of former President Jair Bolsonaro, edged Lula in the first round and has named a cannabis executive as his pick for health minister. With the October 25 runoff days away, Brazil’s patient associations fear a market built for corporations, while investors see an opening in Latin America’s biggest economy. |
| Oct 19, 2026 |
Uganda’s new hemp and medical cannabis cooperative aims to organize farmers, investors
A newly established cooperative in Uganda is seeking to organize farmers and attract investment in industrial hemp and medical cannabis. The Uganda Medical Cannabis and Industrial Hemp Cooperative Society (UMCHICS) is intended to connect licensed producers, investors and government institutions while establishing standards for product quality, traceability and regulatory compliance. At a meeting in Kampala in early October, government officials acknowledged the economic potential of the two crops while warning that licensed operators face penalties for diverting cannabis into illegal markets. |
| Oct 19, 2026 |
What Canada’s Cannabis Shelves Teach About Grading
Every maturing market ends up with a cheap tier and a premium tier. The hard part is proving the premium tier deserves its price. Canada’s legal cannabis market offers an unusual case, because its top grades have no official standard behind them. In Canada, legal since 2018, adults can buy top shelf bud from curated craft ranges that sellers rank above everyday stock. This is information, not an invitation to buy, and the legal age is 19 in most provinces, 18 in Alberta and 21 in Quebec. These sellers ship within Canada only, so readers in Nigeria and across Africa cannot order. Cannabis also remains illegal in Nigeria, and rules differ from country to country. Treat this as a business case for adult readers, not health guidance. |
| Oct 19, 2026 |
Cannabis formulation reduces morphine use by nearly half in clinical trial
A cannabis-based medicine significantly reduced morphine use among hospital patients with severe nerve-related pain, according to the results of a new clinical trial. The study, published in the Journal of Cannabis Research, found that patients given a higher dose of cannabis used 47.6% less morphine over 24 hours than those given a placebo. Despite receiving considerably less morphine, patients in the cannabinoid group did not report significantly higher pain levels, suggesting that cannabis-based medicines could potentially reduce the amount of opioid medication required to manage acute pain. |
| Oct 19, 2026 |
Do THC And CBD Degrade Over Time At Room Temperature?
“To maximize cannabinoid shelf-life and prevent degradation, storage temperatures must match product composition. While CBD-dominant products can tolerate room-temperature storage, THC-rich products require cold chain management, ideally stored in a freezer at -20°C for optimal long-term potency.” the researchers concluded. |
| Oct 19, 2026 |
Morocco's exports of legal cannabis have expanded to 15 countries
Morocco's legal cannabis industry is expanding its international presence, with cannabis resin exports now reaching 15 countries, including France, Switzerland, Portugal, Luxembourg, the Czech Republic, Australia, and South Africa. As the kingdom seeks to establish itself in the global market for cannabis-derived products, its 2026 harvest comes amid stricter regulatory controls as well as a commitment to protecting the identity of its cannabis abroad. |
| Oct 18, 2026 |
Why Is Marijuana Regulated More Strictly Than Alcohol, Even Though It Is Safer To Use? (Op-Ed)
I read the commentary piece by Robert Mellion, executive director of the Massachusetts Package Stores Association, with great bemusement. He argues that oversight of the state’s cannabis sector has been lax and that it should be regulated like alcohol. I think he has it backwards in two fundamental ways. First, alcohol is a much more deadly intoxicant than cannabis. Full stop. It’s worth wondering out loud whether alcohol and cannabis should have the same regulatory regime. Under the existing legal cannabis industry, there have been zero reported deaths from legal cannabis use. The same is not true of alcohol use. Second, cannabis is regulated more comprehensively than virtually any other retail product sold in Massachusetts. |
| Oct 17, 2026 |
First cannabis market study in Missouri finds that legal sales are thriving
The first state-funded study since cannabis was legalized for recreational use in November 2022 found that Missouri’s regulated market has captured 93% of all marijuana transactions, and sales are evenly distributed across the state. The study also found that most consumers purchase flower or “weed” rather than alternatives, and monthly expenditures among all cannabis products averages $161.18 per consumer. Their purchasing decisions are largely driven by price, convenience and strength of the psychoactive substance THC, according to the study results. Overall, the study concluded that the cannabis market is stable and consumers are satisfied with the legal supply available in the state. |
| Oct 17, 2026 |
The first plant-based medical THC spray arrives in the United Kingdom
The Irish pharmaceutical laboratory Dunbar Pharma launches the country's first plant-based THC mouth spray. Made by its British partner IPS Pharma, this new formulation offers an additional administration option to medical specialists, just two months after the launch of THC capsules by the two companies. |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87